The U.S. Environmental Protection Agency awarded Dr. Abraham Nyska with the Level III 2017 Scientific and Technological Achievement Award. The prestigious STAA award is presented to those who have accomplished an unusually notable research or technological effort that relates to a mission of the EPA.
According to the EPA, four award levels are granted in each research category:
- Level I: Level I awards are for those who have accomplished an exceptionally high-quality research or technological effort. The awards recognize the creation or general revision of scientific or technological principle or procedure, or a highly significant improvement in the value of a device, activity, program, or service to the public. Awarded research is of national significance or has high impact on a broad area of science/technology. The research has far reaching consequences and is recognizable as a major scientific/technological achievement within its discipline or field of study.
- Level II: Level II awards are for those who have accomplished a notably excellent research or technological effort that has qualities and values similar to, but to a lesser degree, than those described under Level I. Awarded research has timely consequences and contributes as an important scientific/technological achievement within its discipline or field of study.
- Level III: Level III awards are for those who have accomplished an unusually notable research or technological effort. The awards are for a substantial revision or modification of a scientific/technological principle or procedure, or an important improvement to the value of a device, activity, program, or service to the public. Awarded research relates to a mission or organizational component of the EPA, or significantly affects a relevant area of science/technology.
- Honorable Mention: Honorable Mention awards acknowledge research efforts that are noteworthy but do not warrant a Level I, II or III award. Honorable Mention applies to research that: (1) may not quite reach the level described for a Level III award; (2) show a promising area of research that the Subcommittee wants to encourage; or (3) show an area of research that the Subcommittees feels is too preliminary to warrant an award recommendation at this time.
Dr. Nyska received the Level III award for his work titled, “Evaluating naturally occurring asbestos toxicity to inform risk assessment of contaminated sites,” a study conducted by the NHEERL.
Dr. Nyska is Augmentiqs Chief Medical Advisor for toxicologic pathology. He has over 40 years of experience as a toxicologic pathologist, is a member of the NIH scientific advisory board and serves as an Associate Editor of “Toxicologic Pathology”. Dr. Nyska has over 400 publications in peer-reviewed journals.